共 50 条
- [31] Survival Probability and Survival Benefit Associated With Primary Prevention Implantable Cardioverter-Defibrillator Generator Changes JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2022, 11 (13):
- [32] Gender Differences in Implantable Cardioverter-Defibrillator Utilization for Primary Prevention of Sudden Cardiac Death Current Treatment Options in Cardiovascular Medicine, 2021, 23
- [34] Implantable cardioverter defibrillator for primary prevention in patients with non-ischemic cardiomyopathy in the era of novel therapeutic agents- meta-analysis FRONTIERS IN CARDIOVASCULAR MEDICINE, 2023, 10
- [36] Effectiveness of implantable cardioverter defibrillator as primary prevention in hypertrophic cardiomyopathy: One year follow-up study REVISTA LATINOAMERICANA DE HIPERTENSION, 2023, 18 (01): : 20 - 25
- [38] Atrial fibrillation predicts appropriate shocks in primary prevention implantable cardioverter-defibrillator patients EUROPACE, 2006, 8 (08): : 566 - 572
- [39] Lack of Prognostic Value of T-Wave Alternans for Implantable Cardioverter-Defibrillator Benefit in Primary Prevention JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2024, 13 (11):
- [40] Comparative Evaluation of Four Risk Scores for Predicting Mortality in Patients With Implantable Cardioverter-defibrillator for Primary Prevention REVISTA ESPANOLA DE CARDIOLOGIA, 2016, 69 (11): : 1033 - 1041